Swiss NGO Public Eye has again accused the Swiss food giant Nestlé of selling over-sugared baby food in Africa.

Campaigners say the company is contributing to rising rates of childhood obesity, while the firm says it is helping to combat malnutrition Nestlé is still adding sugar to most baby cereals sold across Africa, according to an investigation by campaigners who have accused the company of “putting the health of African babies at risk for profit”. The food firm was accused of “double standards” over the researchers’ findings, which come at a time when rates of childhood obesity are rising on the continent, prompting calls for Nestlé to remove all added sugar from baby-food products. Continue reading...

More than 50 years since the baby formula scandal, a new investigation focusing on Africa shows that, regarding sugar, a similar malpractice continues. In contrast to India where, after our ...

Aus der Liebe und Fürsorge von Eltern auf der ganzen Welt macht Nestlé ein äusserst profitables Geschäft rund um die Ernährung von Kleinkindern. Aber zu welchem Preis? Anderthalb Jahre nach unserem er...

Nestlé exploite l’amour et les inquiétudes des parents, aux quatre coins du monde, pour transformer l’alimentation des jeunes enfants en un business très lucratif. Mais à quel prix? Une nouvelle enquê...

Campaigners say the company is contributing to rising rates of childhood obesity, while the firm says it is helping to combat malnutrition

The US government is pressing ahead with plans to bring drug prices more into line with those in other countries, including Switzerland.

An exclusive tally of Roche’s patent portfolio for its four monoclonal antibodies (“mAb”) treatments for breast cancer shows that, 27 years after the first product hit the market, about 100 patents st...

An exclusive tally of Roche’s patent portfolio for its four monoclonal antibodies (“mAb”) treatments for breast cancer shows that, 27 years after the first product hit the market, about 100 patents st...

Public Eye hat in einer aufwendigen Pionierstudie die Roche-Patente für seine vier Antikörpertherapien («mAb») gegen Brustkrebs gezählt. Das Resultat: 27 Jahre nach der ersten Markteinführung schützen...

Roche approached the Supreme Court after the Delhi High Court division bench refused to bar Natco Pharma from selling the generic version of Risdiplam which is used to treat a rare genetic disorder th...

Image from here In a huge development concerning the Risdiplam litigation saga, a division bench of the Delhi High Court has rejected the appeal against the order refusing to grant an interim injun…

The division bench upheld the single-judge bench’s findings, which cited public interest in ensuring affordable access to SMA treatment, allowing Natco Pharma to launch a lower-cost generic despite Ro...

Eine exklusive Recherche von Public Eye und Unearthed zeigt, dass die Europäische Union im Jahr 2024 fast 122’000 Tonnen verbotene Pestizide exportiert hat. Dabei hatte sich die EU-Kommission verpflic...

L’Union européenne a exporté près de 122'000 tonnes de pesticides interdits en 2024, alors que la Commission s'était engagée à faire cesser cette pratique. La majorité de ces volumes est destinée à de...

The European Union exported nearly 122,000 tonnes of banned pesticides in 2024, despite a European Commission commitment to put an end to the practice, a new Public Eye and Unearthed investigation has...

CEO Vasant Narasimhan believes that countries outside the USA have a duty to contribute more to innovation.

The adoption of the pandemic agreement at the World Health Assembly earlier this year was hailed by many as a milestone.

Trumps Zollhammer zeigt Parallelen zur helvetischen Aussen­wirtschafts­politik. Wie der US-Präsident nutzen auch die hiesigen Branchen ihre globale Machtposition aus.

Le Lunsumio, traitement prometteur contre le cancer, ne sera plus disponible pour les nouveaux patients. Un bras de fer sur les prix oppose le géant pharmaceutique à l’OFSP.

Onkologen wie Thilo Zander sind verärgert. Roche will vom Bundesamt für Gesundheit einen höheren Preis für ein wirksames Krebsmedikament. Weil das nicht klappt, erhalten es Patienten nicht mehr.

Switzerland and its EFTA partners are set to sign a free trade agreement with Malaysia before the end of June. A leak of its intellectual property annex now reveals that the negotiated accor...

Eine Recherche von Public Eye zeigt erstmals das Ausmass der Seitenwechsel von Mitarbeitenden zwischen der Pharmaindustrie und den beiden Regulierungsbehörden Swissmedic und Bundesamt für Gesundheit (...

Une enquête de Public Eye montre pour la première fois l’ampleur des mouvements de personnel entre l’industrie pharmaceutique et deux autorités de régulation, Swissmedic et l’Office fédéral de la sant...